Office of Biotechnology Activities    National Institutes of Health - Office of Science Policy   RAC June 20, 2002 - Presentation Materials Day 1 Bethesda, Maryland Discussion of Human Gene Transfer Protocol #0201-523 entitled     Phase I Trial of Intraperitoneal Administration of an Attenuated Strain (Edmonston strain) of Measles Virus, Genetically Engineered to Produce Carcinoembryonic Antigen, in Patients With Recurrent Ovarian Cancer     Evanthia Galanis, M.D., Mayo Clinic Jeff Sloan, Ph.D., Mayo Clinic     Slides Webcast     Discussion of Human Gene Transfer Protocol #0201-521 entitled     Inducible Nitric Oxide Synthase Gene Therapy for the Prevention of Intimal Hyperplasia in Arteriovenous Grafts Used for Hemodialysis Access     Edith Tzeng, M.D., University of Pittsburgh Medical Center     Slides Webcast part 1 Webcast part 2     Discussion of Human Gene Transfer Protocol #0201-528 entitled     Pilot Study of the Use of the Human hSlo/maxi-K Gene to Treat Erectile Dysfunction     Arnold Melman, M.D., Albert Einstein College of Medicine     Slides Webcast part 1 Webcast part 2     John Mulcahy, M.D., Indiana University School of Medicine     Slides     Mark Nelson, Ph.D., University of Vermont     Slides     Discussion of Human Gene Transfer Protocol #0201-529 entitled     Gene Transfer for Intractable Pain: A Phase I Clinical Trial to Determine the Maximum Tolerable Dose of a Replication-Defective HSV Vector Expressing Human Proenkephalin     David Fink, M.D., University of Pittsburgh School of Medicine     Slides Webcast part 1 Webcast part 2     ADJOURN     Top of Page

6705 Rockledge Drive, Suite 750, MSC 7985 Bethesda, MD 20892-7985 (For all non-USPS mail, please use ZIP code 20817) Phone: 301-496-9838, Fax: 301-496-9839 E-mail OBA at oba@od.nih.gov

RDNA328